Fig. 4: Immunohistochemistry of PD-L1 in R and 3 NR patients.
A The responding patients had negative TPS and positive CPS (27%). The non-responding patients had negative TPS and positive CPS, 25% (B), 30% (C), and 25% (D), respectively.
Fig. 4: Immunohistochemistry of PD-L1 in R and 3 NR patients. | Cancer Gene Therapy
